US Pharma Firm Moderna's COVID Vaccine Candidate Enters Late-Stage Trial

Moderna said on Monday it has started a US government-backed late-stage trial to assess its COVID-19 vaccine candidate in about 30,000 adults who do not have the respiratory illness caused by the new...